US FDA Reorg: Centers Will Report Directly To Gottlieb; 'Flattened' Structure Will Make Future Political Transitions Easier

Principal Deputy Commissioner Sherman remains top policy guru and will oversee consolidation of functions currently scattered throughout FDA into the Office of Operations.

FDA entrance sign 2016

The US FDA's proposed reorganization of the Office of the Commissioner will elevate the agency’s medical product centers to report directly to Commissioner Scott Gottlieb, as part of a “flattening” of the org chart that announced in an all-FDA email to staff on July 19.

The six center directors – including Center for Drug Evaluation & Research Janet Woodcock – will report directly to Gottlieb,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pink Sheet